Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001390777 | SCV001592619 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2023-08-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1076779). This variant has not been reported in the literature in individuals affected with SGCG-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu171*) in the SGCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCG are known to be pathogenic (PMID: 18285821). |
Revvity Omics, |
RCV001390777 | SCV002021238 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2022-07-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001390777 | SCV002782527 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2024-04-03 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001390777 | SCV004201038 | likely pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2024-02-05 | criteria provided, single submitter | clinical testing |